SCHEMBL1065353

SCHEMBL1065353

NOC(=O)CCCCCCCC(=O)ON

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.42
TSHR P16473 3/20 0.41
LMNA P02545 6/20 0.40
NFKB1 P19838 1/20 0.40
PMP22 Q01453 1/20 0.40
PAM P19021 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
PLG P00747 1/20 0.38
THRB P10828 1/20 0.38
ALOX15 P16050 1/20 0.38
SLC6A2 P23975 1/20 0.38
RECQL P46063 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP1A2 P05177 1/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
PAOX Q6QHF9 1/20 0.36
HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL515782 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL27738121 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL27672248 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL9593894 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL1064431 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL2180897 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL27705302 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL9593713 1.00 DGKA (0.42) DGKATSHRLMNANFKB1PMP22
SCHEMBL27569510 0.97 DGKA (0.41) DGKATSHRLMNANFKB1PMP22
SCHEMBL28175756 0.97 DGKA (0.41) DGKATSHRLMNANFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103119208-A A biocidal polyolefin yarn with 3-12 filaments VESTERGAARD FRANDSEN SA 2013-05-22 CN claimed
CN-112582179-B Electrolytic capacitor 深圳新宙邦科技股份有限公司 2022-07-19 CN disclosed
CN-112582179-A Electrolytic capacitor 深圳新宙邦科技股份有限公司 2021-03-30 CN disclosed
EP-2263996-B1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE TORAY INDUSTRIES (JP) 2016-09-14 EP disclosed
CN-103119208-A A biocidal polyolefin yarn with 3-12 filaments VESTERGAARD FRANDSEN SA 2013-05-22 CN disclosed
US-8334411-B2 Process for producing diamine and polyamide TORAY INDUSTRIES, INC. (JP) 2012-12-18 US disclosed
CN-1930335-B Yarn, fabric and clothes for arc and flame protection DU PONT 2011-06-22 CN disclosed
US-20110004018-A1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE TORAY INDUSTRIES, INC. (JP) 2011-01-06 US disclosed
EP-2263996-A1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE Toray Industries, Inc. (JP) 2010-12-22 EP disclosed
CN-1930335-A Modacrylic/aramid fiber blends for arc and flame protection DU PONT (US) 2007-03-14 CN disclosed
EP-0807118-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1997-11-19 EP disclosed
EP-0759917-A1 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES GILEAD SCIENCES, INC. (US) 1997-03-05 EP disclosed
WO-1996026933-A9 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES 1996-11-28 WO disclosed
WO-1996023801-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1996-08-08 WO disclosed
EP-0719274-A1 METHOD FOR DOSING THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 1996-07-03 EP disclosed
EP-0719273-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1996-07-03 EP disclosed
WO-1995007920-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1995-03-23 WO disclosed
WO-1995007919-A1 METHOD FOR DOSING THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 1995-03-23 WO disclosed
US-4237131-A BRONCHODILATORS BEECHAM GROUP LIMITED (GB) 1980-12-02 US disclosed
EP-0006719-A1 Prostaglandin analogue imidazole derivatives, processes for their preparation and a pharmaceutical composition containing them BEECHAM GROUP PLC (GB) 1980-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110004018-A1 PROCESS FOR PRODUCING DIAMINE AND POLYAMIDE NAAA, PUF60, DNPEP DGKA 337/4885TSHR 3526/4885LMNA 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.